Armin Lahm

Title: Armin Lahm: Innovator in Immunology

Introduction

Armin Lahm is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of immunology, particularly in enhancing T cell responses to vaccines. His innovative work has implications for treating various diseases, including tumor diseases.

Latest Patents

Armin Lahm holds 1 patent for his invention titled "Composition and uses of teleost invariant chain to enhance T cell response to a vaccine." This patent describes polypeptides comprising a fragment of a teleost invariant chain fused to one or more antigens, which can enhance T cell response. The invention also includes polynucleotides encoding such polypeptides and vectors comprising these polynucleotides. The use of these polypeptides and vectors for treating or preventing diseases, particularly tumor diseases, is encompassed by this patent.

Career Highlights

Armin Lahm is currently associated with Nouscom AG, where he continues to advance his research in immunology. His work focuses on the development of innovative solutions to enhance immune responses, which is crucial for effective vaccine development.

Collaborations

He collaborates with notable colleagues, including Alfredo Nicosia and Elisa Scarselli, to further his research and development efforts in the field.

Conclusion

Armin Lahm's contributions to immunology through his innovative patents and collaborations highlight his role as a key figure in advancing vaccine technology. His work has the potential to significantly impact the treatment and prevention of diseases.